Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Awakn Life Sciences Corp (AWKN.CN)

Awakn Life Sciences Corp (AWKN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 3,836
  • Shares Outstanding, K 40,377
  • Annual Sales, $ 87 K
  • Annual Income, $ -5,103 K
  • 60-Month Beta 2.38
  • Price/Sales 31.61
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AWKN.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.18
  • Most Recent Earnings $-0.04 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0600 +58.33%
on 06/27/24
0.1600 -40.63%
on 05/31/24
-0.1000 (-51.28%)
since 05/10/24
3-Month
0.0600 +58.33%
on 06/27/24
0.2300 -58.70%
on 04/09/24
-0.0100 (-9.52%)
since 03/28/24
52-Week
0.0550 +72.73%
on 11/17/23
0.3600 -73.61%
on 10/30/23
-0.1250 (-56.82%)
since 06/28/23

Most Recent Stories

More News
Awakn Life Sciences Announces Closing of Tranche of Private Placement

Toronto, Ontario--(Newsfile Corp. - June 4, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.0750 (+2.32%)
AWKN.CN : 0.0950 (unch)
Awakn Life Sciences Discusses Filing of Financial Statements

Toronto, Ontario--(Newsfile Corp. - May 2, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.0750 (+2.32%)
AWKN.CN : 0.0950 (unch)
Awakn Life Sciences Announces Closing of Tranche of Private Placement

Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.0750 (+2.32%)
AWKN.CN : 0.0950 (unch)
Awakn Life Sciences Announces Launch of Licensing Partnership Agreement with Oklahoma Based Clinic

Awakn also announces Private PlacementToronto, Ontario--(Newsfile Corp. - April 3, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology...

AWKNF : 0.0750 (+2.32%)
AWKN.CN : 0.0950 (unch)
Canadian Securities Exchange Reports February 2024 Performance Figures

Toronto, Ontario--(Newsfile Corp. - March 15, 2024) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced market statistics for February 2024.February 2024 Operating StatisticsTrading...

AWKN.CN : 0.0950 (unch)
BGX.CN : 5.9500 (unch)
PXI.CN : 0.0200 (unch)
Canadian Securities Exchange Welcomes Listing of Awakn Life Sciences Corp

Toronto, Ontario--(Newsfile Corp. - February 13, 2024) - The Canadian Securities Exchange ("CSE" or "the Exchange") today welcomed the listing of Awakn Life Sciences Corp., a clinical-stage biotechnology...

AWKN.CN : 0.0950 (unch)
Awakn Life Sciences Announces Listing on the Canadian Securities Exchange

Toronto, Ontario--(Newsfile Corp. - February 12, 2024) - Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.0750 (+2.32%)
AWKN.CN : 0.0950 (unch)
AWKN.NE : 0.1100 (-21.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people...

See More

Key Turning Points

3rd Resistance Point 0.0950
2nd Resistance Point 0.0950
1st Resistance Point 0.0950
Last Price 0.0950
1st Support Level 0.0950
2nd Support Level 0.0950
3rd Support Level 0.0950

See More

52-Week High 0.3600
Fibonacci 61.8% 0.2435
Fibonacci 50% 0.2075
Fibonacci 38.2% 0.1715
Last Price 0.0950
52-Week Low 0.0550

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar